Authors
Loading...
This review reveals treatment updates for ocular surface malignancy in CSCC, suggesting advances in targeted therapies and cancer immunology may improve patient outcomes.
Mir et al. (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: